NPI: 1417975061 · PALMER, AK 99645 · Cardiovascular Disease Physician · NPI assigned 07/18/2006
Authorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
| Authorized Official | LALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL) |
| NPI Enumeration Date | 07/18/2006 |
Other providers sharing the same authorized official: LALOR, PAULA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 130,313 | $8.55M |
| 2019 | 132,333 | $9.52M |
| 2020 | 113,555 | $7.42M |
| 2021 | 132,545 | $9.93M |
| 2022 | 131,843 | $11.19M |
| 2023 | 137,028 | $11.88M |
| 2024 | 132,561 | $8.87M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 40,264 | 34,936 | $11.96M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 15,623 | 13,628 | $7.66M |
| G0378 | Hospital observation service, per hour | 7,075 | 5,244 | $6.11M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 30,536 | 27,398 | $4.46M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 8,091 | 7,332 | $3.32M |
| 41899 | Unlisted procedure, dentoalveolar structures | 2,065 | 1,761 | $3.12M |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 1,551 | 1,342 | $2.41M |
| 70450 | Computed tomography, head or brain; without contrast material | 6,679 | 5,975 | $2.02M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 20,149 | 17,089 | $1.66M |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 23,508 | 19,045 | $1.38M |
| 71045 | Radiologic examination, chest; single view | 17,087 | 14,983 | $1.16M |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1,828 | 1,670 | $1.13M |
| 96375 | Therapeutic injection; each additional sequential IV push | 15,114 | 12,527 | $1.12M |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 8,361 | 7,690 | $864K |
| 59025 | Fetal non-stress test | 2,448 | 1,918 | $844K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1,130 | 1,055 | $844K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 9,558 | 6,853 | $758K |
| 72125 | Computed tomography, cervical spine; without contrast material | 2,462 | 2,230 | $754K |
| 71046 | Radiologic examination, chest; 2 views | 8,113 | 7,503 | $659K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 758 | 686 | $620K |
| 96361 | Intravenous infusion, hydration; each additional hour | 13,820 | 11,542 | $618K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 4,640 | 3,052 | $544K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1,816 | 1,668 | $533K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 1,559 | 1,430 | $495K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 5,253 | 3,785 | $422K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4,104 | 3,857 | $420K |
| 80053 | Comprehensive metabolic panel | 53,318 | 44,086 | $416K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 13,902 | 12,420 | $399K |
| 96376 | 4,198 | 3,024 | $380K | |
| 70498 | 566 | 508 | $362K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 10,680 | 8,775 | $351K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 6,953 | 6,409 | $346K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 7,287 | 6,712 | $332K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 806 | 724 | $303K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 51,705 | 42,421 | $297K |
| C1776 | Joint device (implantable) | 75 | 64 | $275K |
| 99232 | Subsequent hospital care, per day, moderate complexity | 2,956 | 872 | $272K |
| 93976 | 1,839 | 1,640 | $258K | |
| 73130 | 1,953 | 1,791 | $249K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1,643 | 1,442 | $243K |
| 73030 | 1,867 | 1,715 | $217K | |
| 70496 | 357 | 321 | $214K | |
| 73610 | 2,143 | 1,986 | $207K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 3,717 | 3,009 | $189K |
| 93971 | 1,253 | 1,160 | $185K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 3,396 | 2,542 | $184K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1,541 | 750 | $163K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 1,542 | 1,438 | $147K |
| 73630 | 1,877 | 1,745 | $130K | |
| 84443 | Thyroid stimulating hormone (TSH) | 9,162 | 8,475 | $123K |
| 84484 | 15,277 | 9,302 | $117K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 20,721 | 16,919 | $116K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 4,204 | 3,126 | $115K |
| 99233 | Prolong inpt eval add15 m | 831 | 545 | $109K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 295 | 270 | $108K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 12,257 | 11,236 | $97K |
| 73110 | 1,509 | 1,401 | $97K | |
| 73562 | 1,908 | 1,731 | $95K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 16,228 | 13,582 | $94K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2,902 | 2,689 | $94K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2,898 | 2,688 | $92K |
| 70486 | 286 | 260 | $90K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | 1,882 | 733 | $89K |
| 74018 | 1,460 | 1,307 | $89K | |
| J2704 | Injection, propofol, 10 mg | 12,322 | 9,923 | $88K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3,271 | 3,073 | $86K |
| 72100 | 980 | 929 | $79K | |
| C1769 | Guide wire | 515 | 467 | $79K |
| 80306 | 5,510 | 4,824 | $72K | |
| 85027 | 14,102 | 11,967 | $69K | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 2,684 | 2,021 | $68K |
| 97597 | 1,360 | 732 | $68K | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 573 | 510 | $67K |
| 12001 | 839 | 790 | $66K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 13,334 | 10,112 | $65K |
| 83735 | 14,266 | 11,462 | $64K | |
| 99223 | Prolong inpt eval add15 m | 266 | 246 | $64K |
| 83690 | 11,580 | 10,053 | $62K | |
| 10060 | 561 | 514 | $60K | |
| 84703 | 8,759 | 7,838 | $57K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 202 | 166 | $55K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 8,289 | 7,546 | $52K |
| 82077 | 4,286 | 3,461 | $52K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 9,690 | 8,363 | $51K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 517 | 485 | $51K |
| 80048 | Basic metabolic panel (calcium, ionized) | 8,622 | 7,119 | $48K |
| 87040 | 6,317 | 3,267 | $48K | |
| 83880 | 2,150 | 1,889 | $45K | |
| 73140 | 802 | 747 | $44K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1,824 | 1,720 | $44K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 2,036 | 1,902 | $44K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 2,347 | 1,875 | $43K |
| 81003 | 24,724 | 21,468 | $43K | |
| 97602 | 1,432 | 244 | $43K | |
| C1751 | Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) | 930 | 803 | $42K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 840 | 168 | $41K |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 246 | 226 | $40K |
| 80061 | Lipid panel | 3,608 | 3,433 | $39K |
| 99238 | Hospital discharge day management, 30 minutes or less | 467 | 410 | $38K |
| J0690 | Injection, cefazolin sodium, 500 mg | 6,249 | 4,619 | $37K |
| 90715 | 1,607 | 1,491 | $37K | |
| 74022 | 290 | 272 | $37K | |
| 73080 | 454 | 431 | $35K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 490 | 470 | $35K |
| 80143 | 2,518 | 2,067 | $33K | |
| 83605 | 4,497 | 3,534 | $33K | |
| 80179 | 2,453 | 2,026 | $32K | |
| 84702 | 2,440 | 1,827 | $32K | |
| 99152 | 447 | 395 | $32K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 6,252 | 5,465 | $31K |
| 93798 | 587 | 110 | $31K | |
| 97161 | 825 | 681 | $30K | |
| 73502 | 607 | 526 | $30K | |
| 73590 | 317 | 294 | $30K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1,030 | 974 | $30K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 1,134 | 1,048 | $29K |
| 87186 | 4,239 | 3,910 | $29K | |
| 86850 | 4,383 | 3,834 | $28K | |
| 12002 | 282 | 269 | $27K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 3,743 | 3,480 | $27K |
| 87070 | 3,877 | 3,490 | $27K | |
| 86803 | 2,141 | 2,010 | $27K | |
| J3370 | Injection, vancomycin hcl, 500 mg | 1,705 | 955 | $26K |
| 76770 | 265 | 256 | $25K | |
| 81025 | 3,584 | 3,322 | $25K | |
| 29125 | 203 | 191 | $24K | |
| J1170 | Injection, hydromorphone, up to 4 mg | 3,920 | 3,087 | $23K |
| 73090 | 255 | 227 | $22K | |
| 84439 | 3,013 | 2,837 | $22K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 4,500 | 3,253 | $22K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 4,690 | 3,505 | $21K |
| C8929 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography | 29 | 25 | $21K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 3,980 | 3,448 | $20K |
| 70491 | 50 | 49 | $20K | |
| 99292 | 33 | 30 | $20K | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 2,778 | 2,362 | $20K |
| 85379 | 2,643 | 2,409 | $20K | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 1,555 | 1,387 | $20K |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 1,142 | 953 | $19K |
| 99222 | Initial hospital care, per day, moderate complexity | 147 | 113 | $18K |
| J2060 | Injection, lorazepam, 2 mg | 3,193 | 2,633 | $18K |
| 87340 | 2,030 | 1,892 | $18K | |
| 76830 | Ultrasound, transvaginal | 183 | 169 | $18K |
| 76801 | 189 | 161 | $17K | |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 221 | 185 | $17K |
| 82728 | 1,568 | 1,463 | $17K | |
| 87088 | 2,889 | 2,690 | $17K | |
| 85730 | 4,103 | 3,562 | $17K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 27 | 24 | $16K |
| 86140 | 4,281 | 3,671 | $16K | |
| 86920 | 236 | 180 | $16K | |
| 71250 | 83 | 82 | $16K | |
| 85610 | 5,490 | 4,700 | $16K | |
| 36415 | Collection of venous blood by venipuncture | 34,826 | 28,553 | $14K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 73 | 54 | $13K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 142 | 111 | $13K |
| 87077 | 1,739 | 1,609 | $13K | |
| 82962 | 5,765 | 2,847 | $12K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 125 | 105 | $11K |
| 86900 | 5,105 | 4,431 | $11K | |
| 86901 | 5,101 | 4,429 | $11K | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 1,020 | 936 | $11K |
| 82607 | 930 | 884 | $11K | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 1,945 | 1,571 | $11K |
| 87430 | 777 | 738 | $11K | |
| 82803 | 709 | 572 | $10K | |
| 94729 | 112 | 110 | $10K | |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | 428 | 342 | $10K |
| 94726 | 98 | 92 | $10K | |
| 71101 | 83 | 78 | $9K | |
| 97116 | 297 | 180 | $9K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 1,345 | 752 | $9K |
| 88307 | 36 | 26 | $9K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 12 | 12 | $9K |
| 87420 | 679 | 649 | $9K | |
| 36430 | 56 | 37 | $9K | |
| 81001 | 3,227 | 2,922 | $9K | |
| 87210 | 1,722 | 1,534 | $8K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 13 | 12 | $8K |
| 12011 | 127 | 121 | $8K | |
| 83540 | 1,559 | 1,440 | $8K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 1,530 | 1,302 | $8K |
| 83550 | 1,110 | 1,035 | $7K | |
| 86141 | 600 | 506 | $7K | |
| P9016 | Red blood cells, leukocytes reduced, each unit | 58 | 39 | $7K |
| 72040 | 82 | 78 | $7K | |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | 989 | 736 | $7K |
| 86592 | 1,857 | 1,740 | $7K | |
| 87081 | 1,257 | 1,194 | $7K | |
| J1630 | Injection, haloperidol, up to 5 mg | 984 | 823 | $7K |
| J3490 | Unclassified drugs | 917 | 316 | $7K |
| 85652 | 3,225 | 2,879 | $7K | |
| 94060 | 43 | 43 | $6K | |
| J1790 | Injection, droperidol, up to 5 mg | 1,376 | 1,116 | $6K |
| 49083 | 20 | 12 | $6K | |
| 86706 | 607 | 569 | $6K | |
| 99221 | 47 | 45 | $6K | |
| 82947 | 2,407 | 1,500 | $6K | |
| J8540 | Dexamethasone, oral, 0.25 mg | 1,700 | 1,539 | $6K |
| 82570 | 1,199 | 996 | $5K | |
| C9113 | Injection, pantoprazole sodium, per vial | 740 | 545 | $5K |
| J3480 | Injection, potassium chloride, per 2 meq | 481 | 376 | $4K |
| J7030 | Infusion, normal saline solution , 1000 cc | 278 | 205 | $4K |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 1,718 | 1,492 | $4K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 582 | 482 | $4K |
| 96368 | 61 | 55 | $4K | |
| 76870 | 25 | 24 | $4K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 24 | 24 | $4K |
| C1889 | Implantable/insertable device, not otherwise classified | 15 | 14 | $4K |
| 84100 | 1,283 | 1,007 | $4K | |
| 80047 | 469 | 422 | $4K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 95 | 84 | $4K |
| J7050 | Infusion, normal saline solution, 250 cc | 73 | 40 | $4K |
| 84481 | 223 | 213 | $3K | |
| 88342 | 44 | 37 | $3K | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 1,258 | 1,075 | $3K |
| 96367 | 45 | 37 | $3K | |
| 86762 | 210 | 199 | $3K | |
| J3411 | Injection, thiamine hcl, 100 mg | 1,014 | 773 | $3K |
| 72072 | 26 | 26 | $3K | |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 130 | 117 | $2K |
| J1756 | Injection, iron sucrose, 1 mg | 48 | 24 | $2K |
| 76937 | 12 | 12 | $2K | |
| C9290 | Injection, bupivacaine liposome, 1 mg | 62 | 46 | $2K |
| 86705 | 205 | 191 | $2K | |
| 84403 | 91 | 90 | $2K | |
| 84156 | 544 | 434 | $2K | |
| J2560 | Injection, phenobarbital sodium, up to 120 mg | 295 | 229 | $2K |
| 87653 | 59 | 52 | $2K | |
| 73560 | 71 | 58 | $2K | |
| 84144 | 96 | 87 | $2K | |
| 84550 | 366 | 298 | $1K | |
| 86038 | 111 | 108 | $1K | |
| 82746 | 126 | 120 | $1K | |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 62 | 57 | $1K |
| 87205 | 343 | 292 | $1K | |
| 84112 | 16 | 14 | $1K | |
| 82550 | 225 | 185 | $1K | |
| 29126 | 12 | 12 | $1K | |
| 82784 | 104 | 89 | $1K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 36 | 25 | $1K |
| 88304 | 18 | 17 | $1K | |
| 85014 | 578 | 498 | $1K | |
| 87075 | 195 | 156 | $964.71 | |
| 90714 | 52 | 49 | $958.06 | |
| J0515 | Injection, benztropine mesylate, per 1 mg | 32 | 27 | $919.82 |
| 82105 | 54 | 53 | $919.37 | |
| 82247 | 191 | 122 | $897.85 | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 24 | 15 | $807.92 |
| 82565 | 145 | 114 | $737.35 | |
| J7643 | Glycopyrrolate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram | 22 | 19 | $640.67 |
| 84145 | 31 | 25 | $536.84 | |
| 83001 | 36 | 36 | $533.22 | |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | 147 | 133 | $496.63 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 72 | 64 | $489.88 |
| 85007 | 166 | 146 | $486.33 | |
| 80074 | 13 | 12 | $455.78 | |
| 82248 | 98 | 81 | $453.44 | |
| 84520 | 110 | 83 | $438.25 | |
| 51702 | 14 | 12 | $373.63 | |
| J2470 | Injection, pantoprazole sodium, 40 mg | 68 | 54 | $347.76 |
| 82670 | 14 | 14 | $345.02 | |
| 82950 | 61 | 61 | $329.48 | |
| 82150 | 41 | 40 | $306.00 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 93 | 72 | $277.12 |
| 83970 | 15 | 12 | $274.54 | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 307 | 268 | $244.98 |
| 84153 | 15 | 15 | $227.11 | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 60 | 53 | $223.72 |
| 86677 | 14 | 13 | $177.30 | |
| J1171 | Injection, hydromorphone, 0.1 mg | 48 | 41 | $155.00 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 2,823 | 2,478 | $154.33 |
| 94760 | 37 | 25 | $148.24 | |
| J0461 | Injection, atropine sulfate, 0.01 mg | 38 | 37 | $122.40 |
| 80069 | 20 | 14 | $122.16 | |
| J1940 | Injection, furosemide, up to 20 mg | 42 | 24 | $109.01 |
| 84450 | 16 | 12 | $103.98 | |
| 80076 | 12 | 12 | $97.90 | |
| 84460 | 14 | 12 | $93.07 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 12 | 12 | $67.98 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1,291 | 1,202 | $59.88 |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | 534 | 493 | $35.91 |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | 13 | 12 | $6.89 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 480 | 411 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 1,035 | 856 | $0.00 |
| 99001 | 114 | 110 | $0.00 | |
| J0694 | Injection, cefoxitin sodium, 1 gm | 16 | 13 | $0.00 |
| 36416 | 19 | 12 | $0.00 | |
| G0475 | Hiv antigen/antibody, combination assay, screening | 17 | 17 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 73 | 65 | $0.00 |
| 86364 | 17 | 17 | $0.00 |